Safeguarding Women’s and Children’s Health Act of 2022
Official title: To require more accurate reporting of abortion drug prescribing and related adverse events, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Safeguarding Women's and Children's Health Act of 2022
This bill imposes reporting requirements relating to abortion drugs.
The Food and Drug Administration (FDA) must require health care practitioners to report (1) any death or adverse event associated with the use of an abortion drug, whether or not the adverse event is considered drug-related; and (2) each time the practitioner prescribes, dispenses, or administers such a drug.
The FDA must establish online portals for health care practitioners to report such information and for patients to self-report adverse events.
The Centers for Disease Control and Prevention must aggregate the collected information and annually publish data about such drugs, including the number of prescriptions and adverse events occurring within 120 days of use.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 6702: Safeguarding Women’s and Children’s Health Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-HR-6702/
"H.R. 6702: Safeguarding Women’s and Children’s Health Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-6702/.
H.R. 6702, 117th Cong. (2026), https://openamerica.io/bill/117-HR-6702/.
[H.R. 6702: Safeguarding Women’s and Children’s Health Act of 2022](https://openamerica.io/bill/117-HR-6702/)